These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 921240)

  • 21. Comparative nephrotoxicity of gentamicin and tobramycin in rats.
    Gilbert DN; Plamp C; Starr P; Bennet WM; Houghton DC; Porter G
    Antimicrob Agents Chemother; 1978 Jan; 13(1):34-40. PubMed ID: 626489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (9): Protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1990 Jul; 53(3):347-58. PubMed ID: 2391766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
    Earp CM; Barriere SL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):677-9. PubMed ID: 4042863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefamandole---a review of chemistry and microbiology.
    Kaiser GV; Gorman M; Webber JA
    J Infect Dis; 1978 May; 137 Suppl():S10-S16. PubMed ID: 565798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inactivation of tobramycin by cephalosporins.
    Spruill WJ; McCall CY; Francisco GE
    Am J Hosp Pharm; 1985 Nov; 42(11):2506-9. PubMed ID: 3907338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Febrile morbidity following cefamandole nafate intrauterine irrigation during cesarean section.
    Rudd EG; Long WH; Dillon MB
    Am J Obstet Gynecol; 1981 Sep; 141(1):12-6. PubMed ID: 7270617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
    Coppens L; Hanson B; Klastersky J
    Antimicrob Agents Chemother; 1983 Jan; 23(1):36-41. PubMed ID: 6550482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum bactericidal activity against Klebsiella pneumoniae in volunteers receiving increasing doses of tobramycin with or without cefamandole.
    Pascual-Lopez A; Lagast H; Klastersky J
    Int J Clin Pharmacol Res; 1987; 7(1):45-9. PubMed ID: 3294615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.
    Tindula RJ; Ambrose PJ; Harralson AF
    Drug Intell Clin Pharm; 1983 Dec; 17(12):906-8. PubMed ID: 6653408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Toxicity of tobramycin in single and multiple administrations to laboratory animals].
    Gol'dberg LE; Filippos'iants ST; Belova IP; Vertogradova TP; Shepelevtseva NG
    Antibiotiki; 1979 Jan; 24(1):60-7. PubMed ID: 426496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic fate of [14C]cefamandole, a parenteral cephalosporin antibiotic, in rats and dogs.
    Sullivan HR; Due SL; Kau DL; Quay JF; Miller WM
    Antimicrob Agents Chemother; 1977 Jul; 12(1):73-9. PubMed ID: 883820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical stabilities of cefamandole nafate and metronidazole when mixed together for intravenous infusion.
    Das Gupta V; Stewart KR; Dela Torre M
    J Clin Hosp Pharm; 1985 Dec; 10(4):379-83. PubMed ID: 4093509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat.
    Houghton DC; Plamp CE; DeFehr JM; Bennett WM; Porter G; Gilbert D
    Am J Pathol; 1978 Oct; 93(1):137-52. PubMed ID: 696801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.
    Phillips LE; Martin RF; Luper WE; Rogers TE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):567-70. PubMed ID: 7247379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of frozen solutions of cefamandole nafate.
    Bornstein M; Klink PR; Farrell BT; Winely CL; Boylan JC
    Am J Hosp Pharm; 1980 Jan; 37(1):98-101. PubMed ID: 7361780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of cefamandole nafate and cefoxitin sodium solutions.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin enhancement of experimental tobramycin nephrotoxicity.
    Wood CA; Kohlhepp SJ; Kohnen PW; Houghton DC; Gilbert DN
    Antimicrob Agents Chemother; 1986 Jul; 30(1):20-4. PubMed ID: 3752981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of tobramycin nephrotoxicity in young adult and aged female rats.
    Peters-Volleberg GW; Dortant PM; Speijers GJ
    Pharmacol Toxicol; 1999 Apr; 84(4):147-53. PubMed ID: 10227064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.
    Warren JW; Miller EH; Fitzpatrick B; DiFranco DE; Caplan ES; Tenney JH; Anthony WC
    Rev Infect Dis; 1983; 5 Suppl 1():S173-80. PubMed ID: 6221388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.